Embecta Corp (EMBC) USD0.01

- Add to watchlist
- This stock can be held in a




Business summary
Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company's portfolio of products include a variety of pen needles, syringes and safety devices, which are complemented by its digital applications designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with insulin pens and are used to inject insulin or other diabetes medications. The Company also sells sterile, single-use insulin syringes, safety pen needles, which include resin injection-molded shields on both ends of the cannula that automatically help prevent needlestick exposure and injury during injection and disposal. Its products are used in retail and acute care hospitals, clinics and other institutional channels, healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.
Contact details
Important dates
General stock information
- Short code:
- EMBC
- ISIN:
- US29082K1051
- Market cap:
- $1.55 billion
- Shares in issue:
- 57.80 million
- Sector:
- Health Care Supplies
- Exchange:
- NASDAQ
- Country:
- United States
- Currency:
- US dollar
- Indices:
- n/a
Key personnel

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.